B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1: Rare case and review of the literature

Janese Trimaldi; Estrella M. Carballido; Jeremy W. Bowers; Arturo L. Anguiano; Zhong J. Zhang; Bijal D. Shah; Salvador Bruno; Alan F. List; Lynn C. Moscinski; Terrence Grady; Steven J. Agosti; Loveleen Kang; Ling Zhang

doi:10.1159/000347030

B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1: Rare case and review of the literature

Janese Trimaldi, Estrella M. Carballido, Jeremy W. Bowers, Arturo L. Anguiano, Zhong J. Zhang, Bijal D. Shah, Salvador Bruno, Alan F. List, Lynn C. Moscinski, Terrence Grady, Steven J. Agosti, Loveleen Kang, Ling Zhang

Hematology/Oncology

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

Myeloid and lymphoid neoplasms with fibroblastic growth factor receptor-1 (FGFR1) abnormalities originate from mutated pluripotent stem cells and have a heterogeneous clinical presentation. There are 12 identified partner genes commonly involved in FGFR1 translocation at an 8p11 breakpoint. In FGFR1-related neoplasms, T-lymphoblastic lymphoma with eosinophilia is the most common clinical scenario, whereas acute B-lymphoblastic leukemia/lymphoma (B-ALL/LBL) is rare. To date, only 7 cases of B-ALL/LBL with FGFR1 abnormalities have been reported. Here, we report an additional case of a 64-year-old gentleman with leukocytosis, eosinophilia and diffuse mediastinal and general lymphadenopathy. Bone marrow examination showed patchy infiltrates of immature precursors/blasts, along with myeloid/eosinophilic hyperplasia. Immunophenotyping confirmed increased B lymphoblasts (30-40%). Karyotyping revealed cytogenetic abnormalities, including t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1 and trisomy 21. The patient did not respond to hyper-CVAD chemotherapy and within 4 months developed acute myelomonocytic leukemia and expired 11 months after the initial diagnosis. Similar cases from the literature are reviewed.

Original language	English (US)
Pages (from-to)	127-134
Number of pages	8
Journal	Acta Haematologica
Volume	130
Issue number	3
DOIs	https://doi.org/10.1159/000347030
State	Published - 2013

Keywords

8p11
Acute B-lymphoblastic leukemia/lymphoma
t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1

ASJC Scopus subject areas

Hematology

Access to Document

10.1159/000347030

Cite this

Trimaldi, J., Carballido, E. M., Bowers, J. W., Anguiano, A. L., Zhang, Z. J., Shah, B. D., Bruno, S., List, A. F., Moscinski, L. C., Grady, T., Agosti, S. J., Kang, L., & Zhang, L. (2013). B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1: Rare case and review of the literature. Acta Haematologica, 130(3), 127-134. https://doi.org/10.1159/000347030

Trimaldi, J, Carballido, EM, Bowers, JW, Anguiano, AL, Zhang, ZJ, Shah, BD, Bruno, S, List, AF, Moscinski, LC, Grady, T, Agosti, SJ, Kang, L & Zhang, L 2013, 'B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1: Rare case and review of the literature', Acta Haematologica, vol. 130, no. 3, pp. 127-134. https://doi.org/10.1159/000347030

@article{b84c4984bbf04f098f3db6b322a60db1,

title = "B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1: Rare case and review of the literature",

abstract = "Myeloid and lymphoid neoplasms with fibroblastic growth factor receptor-1 (FGFR1) abnormalities originate from mutated pluripotent stem cells and have a heterogeneous clinical presentation. There are 12 identified partner genes commonly involved in FGFR1 translocation at an 8p11 breakpoint. In FGFR1-related neoplasms, T-lymphoblastic lymphoma with eosinophilia is the most common clinical scenario, whereas acute B-lymphoblastic leukemia/lymphoma (B-ALL/LBL) is rare. To date, only 7 cases of B-ALL/LBL with FGFR1 abnormalities have been reported. Here, we report an additional case of a 64-year-old gentleman with leukocytosis, eosinophilia and diffuse mediastinal and general lymphadenopathy. Bone marrow examination showed patchy infiltrates of immature precursors/blasts, along with myeloid/eosinophilic hyperplasia. Immunophenotyping confirmed increased B lymphoblasts (30-40%). Karyotyping revealed cytogenetic abnormalities, including t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1 and trisomy 21. The patient did not respond to hyper-CVAD chemotherapy and within 4 months developed acute myelomonocytic leukemia and expired 11 months after the initial diagnosis. Similar cases from the literature are reviewed.",

keywords = "8p11, Acute B-lymphoblastic leukemia/lymphoma, t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1",

author = "Janese Trimaldi and Carballido, {Estrella M.} and Bowers, {Jeremy W.} and Anguiano, {Arturo L.} and Zhang, {Zhong J.} and Shah, {Bijal D.} and Salvador Bruno and List, {Alan F.} and Moscinski, {Lynn C.} and Terrence Grady and Agosti, {Steven J.} and Loveleen Kang and Ling Zhang",

note = "Publisher Copyright: Copyright {\textcopyright} 2013 S. Karger AG, Basel.",

year = "2013",

doi = "10.1159/000347030",

language = "English (US)",

volume = "130",

pages = "127--134",

journal = "Acta Haematologica",

issn = "0001-5792",

publisher = "S. Karger AG",

number = "3",

}

TY - JOUR

T1 - B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1

T2 - Rare case and review of the literature

AU - Trimaldi, Janese

AU - Carballido, Estrella M.

AU - Bowers, Jeremy W.

AU - Anguiano, Arturo L.

AU - Zhang, Zhong J.

AU - Shah, Bijal D.

AU - Bruno, Salvador

AU - List, Alan F.

AU - Moscinski, Lynn C.

AU - Grady, Terrence

AU - Agosti, Steven J.

AU - Kang, Loveleen

AU - Zhang, Ling

PY - 2013

Y1 - 2013

N2 - Myeloid and lymphoid neoplasms with fibroblastic growth factor receptor-1 (FGFR1) abnormalities originate from mutated pluripotent stem cells and have a heterogeneous clinical presentation. There are 12 identified partner genes commonly involved in FGFR1 translocation at an 8p11 breakpoint. In FGFR1-related neoplasms, T-lymphoblastic lymphoma with eosinophilia is the most common clinical scenario, whereas acute B-lymphoblastic leukemia/lymphoma (B-ALL/LBL) is rare. To date, only 7 cases of B-ALL/LBL with FGFR1 abnormalities have been reported. Here, we report an additional case of a 64-year-old gentleman with leukocytosis, eosinophilia and diffuse mediastinal and general lymphadenopathy. Bone marrow examination showed patchy infiltrates of immature precursors/blasts, along with myeloid/eosinophilic hyperplasia. Immunophenotyping confirmed increased B lymphoblasts (30-40%). Karyotyping revealed cytogenetic abnormalities, including t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1 and trisomy 21. The patient did not respond to hyper-CVAD chemotherapy and within 4 months developed acute myelomonocytic leukemia and expired 11 months after the initial diagnosis. Similar cases from the literature are reviewed.

AB - Myeloid and lymphoid neoplasms with fibroblastic growth factor receptor-1 (FGFR1) abnormalities originate from mutated pluripotent stem cells and have a heterogeneous clinical presentation. There are 12 identified partner genes commonly involved in FGFR1 translocation at an 8p11 breakpoint. In FGFR1-related neoplasms, T-lymphoblastic lymphoma with eosinophilia is the most common clinical scenario, whereas acute B-lymphoblastic leukemia/lymphoma (B-ALL/LBL) is rare. To date, only 7 cases of B-ALL/LBL with FGFR1 abnormalities have been reported. Here, we report an additional case of a 64-year-old gentleman with leukocytosis, eosinophilia and diffuse mediastinal and general lymphadenopathy. Bone marrow examination showed patchy infiltrates of immature precursors/blasts, along with myeloid/eosinophilic hyperplasia. Immunophenotyping confirmed increased B lymphoblasts (30-40%). Karyotyping revealed cytogenetic abnormalities, including t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1 and trisomy 21. The patient did not respond to hyper-CVAD chemotherapy and within 4 months developed acute myelomonocytic leukemia and expired 11 months after the initial diagnosis. Similar cases from the literature are reviewed.

KW - 8p11

KW - Acute B-lymphoblastic leukemia/lymphoma

KW - t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1

UR - http://www.scopus.com/inward/record.url?scp=84876072541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876072541&partnerID=8YFLogxK

U2 - 10.1159/000347030

DO - 10.1159/000347030

M3 - Review article

C2 - 23594707

AN - SCOPUS:84876072541

SN - 0001-5792

VL - 130

SP - 127

EP - 134

JO - Acta Haematologica

JF - Acta Haematologica

IS - 3

ER -

B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1: Rare case and review of the literature

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this